Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Carole S. Ben-Maimon, M.D., is the CEO of Larimar Therapeutics, Inc., a biotechnology company dedicated to developing treatments for rare and serious diseases. Dr. Ben-Maimons leadership is characterized by a focus on scientific innovation, clinical research, and strategic growth. With extensive experience in drug development and biotechnology, she has guided Larimar Therapeutics through significant advancements in treatment development and clinical trials. Her commitment to advancing medical science and improving patient outcomes continues to drive Larimar Therapeutics success and innovation in the biotech industry.
